Company / Working Capital per Share
Vanda Pharmaceuticals Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$3.47
FY2025
5-year range
$3.47 / $7.65
FY2021-FY2025
Trend
-41.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has declined for 3 consecutive years, from $7.65 in FY2022 to $3.47 in FY2025.
Based on SEC 10-K filings.
3.47 in FY2025 with a 5-year CAGR of -11.6%.
Declined from $6.08 to $3.47 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -23.2%
- 5-Year CAGR
- -11.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Vanda Pharmaceuticals Inc.'s working capital per share has declined for 3 consecutive years.
- In FY2025, working capital per share decreased 41.2% year-over-year.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.47 | -41.2% |
| FY2024 | $5.89 | -3.1% |
| FY2023 | $6.08 | -20.6% |
| FY2022 | $7.65 | +4.0% |
| FY2021 | $7.36 | +14.9% |
| FY2020 | $6.41 | +14.2% |
| FY2019 | $5.61 | +2.5% |
| FY2018 | $5.48 | +142.2% |
| FY2017 | $2.26 | -21.8% |
| FY2016 | $2.89 | +4.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026